发明名称 |
ENHANCED ABSORPTION OF MODIFIED RELEASE DOSAGE FORMS |
摘要 |
Disclosed are products and methods for improving the plasma profile in a patient being treated with a pharmaceutical active agent that is subject to a limited window of absorption, which products and methods comprise orally administering the active agent in multiparticulate form, such that at least a portion thereof is delivered to the intestine while the patient is in the fed condition.
|
申请公布号 |
CA2550983(C) |
申请公布日期 |
2013.09.17 |
申请号 |
CA20042550983 |
申请日期 |
2004.12.23 |
申请人 |
ADVANCIS PHARMACEUTICAL CORPORATION |
发明人 |
TREACY, DONALD J., JR.;FLANNER, HENRY H.;GUTTENDORF, ROBERT J.;BURNSIDE, BETH A. |
分类号 |
A61K9/20;A61K9/16;A61K9/48;A61K9/50;A61K31/43 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|